Panagiotis Panagiotidis

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

Peter Hillmen, Tadeusz Robak, Ann Janssens et al. · The Lancet · 2015 · 337 citations

Hematological Malignancy, Immunohematology, Complement 1 +13

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Viktor Ljungström, Diego Cortese, Emma Young et al. · Blood · 2015 · 150 citations · Full text

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi et al. · Blood · 2020 · 123 citations · Full text

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Panagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton et al. · The Lancet Haematology · 2014 · 111 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +12

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Jonathan C. Strefford, L-A Sutton, Panagiotis Baliakas et al. · Leukemia · 2013 · 101 citations

Hematological Malignancy, Poor-prognostic Stereotyped Subsets, Distinct Patterns +8